Senzime Launches Medical Affairs Division and Education Platform to Drive Transformation in Anesthesia Monitoring
Senzime (SNZZF) has announced two major initiatives to advance anesthesia monitoring practices: the launch of a new Medical Affairs division and the Senzime Academy education platform. The Medical Affairs division, led by Jen Sanders, will focus on collaborating with academic centers and healthcare providers to translate clinical research into practice and address residual neuromuscular block (rNMB) risks.
The company's TetraGraph system, backed by 40+ years of research and featured in 19 peer-reviewed publications, is currently utilized in over 3,500 operating rooms globally. The system's EMG-based platform supports compliance with ASA and ESAIC best practices. The new Senzime Academy offers on-demand training for clinicians on quantitative train-of-four (TOF) monitoring and TetraGraph implementation across adult and pediatric care settings.
Senzime (SNZZF) ha annunciato due importanti iniziative per migliorare le pratiche di monitoraggio anestesiologico: il lancio di una nuova divisione Medical Affairs e della piattaforma educativa Senzime Academy. La divisione Medical Affairs, guidata da Jen Sanders, si concentrerà sulla collaborazione con centri accademici e operatori sanitari per tradurre la ricerca clinica in pratica e affrontare i rischi legati al blocco neuromuscolare residuo (rNMB).
Il sistema TetraGraph dell'azienda, supportato da oltre 40 anni di ricerca e presente in 19 pubblicazioni peer-reviewed, è attualmente utilizzato in più di 3.500 sale operatorie a livello globale. La piattaforma basata su EMG del sistema favorisce il rispetto delle migliori pratiche ASA e ESAIC. La nuova Senzime Academy offre formazione on-demand per i clinici sul monitoraggio quantitativo train-of-four (TOF) e sull’implementazione di TetraGraph in contesti di cura per adulti e pediatrici.
Senzime (SNZZF) ha anunciado dos iniciativas principales para avanzar en las prácticas de monitoreo anestésico: el lanzamiento de una nueva división de Asuntos Médicos y la plataforma educativa Senzime Academy. La división de Asuntos Médicos, dirigida por Jen Sanders, se enfocará en colaborar con centros académicos y proveedores de salud para traducir la investigación clínica en práctica y abordar los riesgos del bloqueo neuromuscular residual (rNMB).
El sistema TetraGraph de la compañía, respaldado por más de 40 años de investigación y presentado en 19 publicaciones revisadas por pares, se utiliza actualmente en más de 3,500 quirófanos a nivel mundial. La plataforma basada en EMG del sistema apoya el cumplimiento de las mejores prácticas de ASA y ESAIC. La nueva Senzime Academy ofrece capacitación bajo demanda para clínicos sobre el monitoreo cuantitativo train-of-four (TOF) y la implementación de TetraGraph en entornos de atención para adultos y pediátricos.
Senzime (SNZZF)는 마취 모니터링 관행을 발전시키기 위한 두 가지 주요 이니셔티브를 발표했습니다: 새로운 의료 업무 부서 출범과 Senzime Academy 교육 플랫폼입니다. Jen Sanders가 이끄는 의료 업무 부서는 학술 기관 및 의료 제공자와 협력하여 임상 연구를 실제에 적용하고 잔여 신경근 차단(rNMB) 위험을 해결하는 데 중점을 둘 예정입니다.
회사에서 개발한 TetraGraph 시스템은 40년 이상의 연구를 기반으로 하며 19개의 동료 검토 논문에 소개되었고, 현재 전 세계 3,500개 이상의 수술실에서 사용되고 있습니다. 이 시스템의 EMG 기반 플랫폼은 ASA 및 ESAIC의 모범 사례 준수를 지원합니다. 새로 출범한 Senzime Academy는 성인 및 소아 치료 환경에서 정량적 train-of-four(TOF) 모니터링과 TetraGraph 구현에 관한 임상의 대상 주문형 교육을 제공합니다.
Senzime (SNZZF) a annoncé deux initiatives majeures pour faire progresser les pratiques de surveillance en anesthésie : le lancement d'une nouvelle division des Affaires Médicales et de la plateforme éducative Senzime Academy. La division des Affaires Médicales, dirigée par Jen Sanders, se concentrera sur la collaboration avec des centres académiques et des professionnels de santé afin de traduire la recherche clinique en pratique et de gérer les risques liés au bloc neuromusculaire résiduel (rNMB).
Le système TetraGraph de la société, soutenu par plus de 40 ans de recherche et présenté dans 19 publications évaluées par des pairs, est actuellement utilisé dans plus de 3 500 salles d'opération à travers le monde. La plateforme basée sur l'EMG du système favorise le respect des meilleures pratiques de l'ASA et de l'ESAIC. La nouvelle Senzime Academy propose une formation à la demande pour les cliniciens sur la surveillance quantitative train-of-four (TOF) et la mise en œuvre de TetraGraph dans les soins aux adultes et aux enfants.
Senzime (SNZZF) hat zwei bedeutende Initiativen zur Verbesserung der Anästhesieüberwachung angekündigt: die Einführung einer neuen Medical Affairs-Abteilung und der Bildungsplattform Senzime Academy. Die Medical Affairs-Abteilung unter der Leitung von Jen Sanders wird sich darauf konzentrieren, mit akademischen Zentren und Gesundheitsdienstleistern zusammenzuarbeiten, um klinische Forschung in die Praxis umzusetzen und Risiken durch residuale neuromuskuläre Blockade (rNMB) anzugehen.
Das TetraGraph-System des Unternehmens, unterstützt durch über 40 Jahre Forschung und veröffentlicht in 19 begutachteten Fachartikeln, wird derzeit in mehr als 3.500 Operationssälen weltweit eingesetzt. Die EMG-basierte Plattform des Systems unterstützt die Einhaltung der besten Praktiken von ASA und ESAIC. Die neue Senzime Academy bietet On-Demand-Schulungen für Kliniker zum quantitativen Train-of-Four (TOF)-Monitoring und zur Implementierung von TetraGraph in der Erwachsenen- und Pädiatrieversorgung an.
- TetraGraph system is implemented in over 3,500 operating rooms worldwide
- Strong scientific backing with 19 peer-reviewed publications
- Expansion of services through new Medical Affairs division and education platform
- Compliance with major medical associations' (ASA and ESAIC) best practices
- None.
UPPSALA,
"These initiatives aim to drive the next wave of clinical transformation in anesthesia care, as Senzime continues to strengthen our role not only as a device innovator, but as a scientific and educational partner," said Philip Siberg, CEO of Senzime. "Our new Medical Affairs team and educational platform reflect our commitment to partnering with providers to implement evidence-based practices that elevate patient outcomes."
Building a Global Clinical Community
Senzime's new Medical Affairs division will serve as a hub for collaboration with leading academic centers, anesthesia providers, and perioperative teams. Its mission is to translate clinical research into real-world practice, support best-in-class implementation, and elevate global awareness about the ongoing risks of residual neuromuscular block (rNMB). The division is led by Jen Sanders, Director of Clinical and Medical Affairs.
Addressing the Real-World Needs of Anesthesia Teams
To support widespread adoption of neuromuscular monitoring, Senzime Academy offers clinicians on-demand training on quantitative train-of-four (TOF) monitoring and best practices for TetraGraph® use. The digital platform includes video modules, clinical case examples, and implementation guides for both adult and pediatric care settings.
Built on 40+ Years of Scientific Research
Senzime's flagship TetraGraph system is the result of over four decades of neuromuscular monitoring research, translated into a clinically robust, EMG-based platform purpose-built to meet the demands of modern surgery. Its proprietary TOF monitoring technology is clinically evaluated in 19 peer-reviewed publications, making it the most studied EMG system available today. TetraGraph is used in over 3,500 operating rooms worldwide, supporting compliance with best practices outlined by the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC).
More information how Senzime's solutions can be used across specialized clinical applications, such as robotic-assisted surgeries, pediatrics, and enhanced recovery after surgery (ERAS), is available at https://senzime.com.
More information about Senzime Academy is available at https://www.senzime.com/en/explore-senzime-academy-anytime-anywhere.
For further information, please contact:
Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com
About Senzime
Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies. Established in 1999, Senzime develops and markets precision-based monitoring systems that improve outcomes, reduce costs, and advance perioperative patient safety. The flagship solution is the TetraGraph® system, proven best-in-class for accurate monitoring of neuromuscular transmission during surgery and used in thousands of operating rooms across the globe. The system helps to secure precise dosing of paralytic drugs and provides enhanced insights to safeguard every patient's journey, from anesthesia to recovery.
Headquartered in Uppsala,
View original content to download multimedia:https://www.prnewswire.com/news-releases/senzime-launches-medical-affairs-division-and-education-platform-to-drive-transformation-in-anesthesia-monitoring-302452337.html
SOURCE Senzime
FAQ
What is the purpose of Senzime's new Medical Affairs division?
How many operating rooms currently use Senzime's TetraGraph system?
What is Senzime Academy and what does it offer?
How is SNZZF's TetraGraph system scientifically validated?
Who leads Senzime's new Medical Affairs division?
